Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
13-20-1|Sr-a-kBq 0,n/a|1|70|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (0 in ERA)|Mouse|Mouse, CBA/S (CBA/SU)|Male|Young Adult|acute effects|No information on individuals available for this study
13-20-2|Sr-l-kBq 0,n/a|1|70|none (controls)|0|unit code not relevant|not applicable or not supplied|n/a|50 (0 in ERA)|Mouse|Mouse, CBA/S (CBA/SU)|Male|Young Adult|late effects|No information on individuals available for this study
13-20-3|Sr-a-kBq 11.1,n/a|1|70|Sr-90 nitrate|11.1|kilobecquerels per g animal|Injection, intravenous|single injection|50 (0 in ERA)|Mouse|Mouse, CBA/S (CBA/SU)|Male|Young Adult|acute effects|No information on individuals available for this study
13-20-4|Sr-l-kBq 11.1,n/a|1|70|Sr-90 nitrate|11.1|kilobecquerels per g animal|Injection, intravenous|single injection|50 (0 in ERA)|Mouse|Mouse, CBA/S (CBA/SU)|Male|Young Adult|late effects|No information on individuals available for this study
